Friday, November 29, 2013

Study: ShockWave therapy and Achilles Tendonopathy.



ANNOUNCEMENT - ACOUSTIC SHOCK WAVE THERAPY (SWT)

Orthopade. 2005 Jun;34(6):571-8.

[Extracorporeal shockwave therapy in the treatment of chronic insertional Achilles tendinopathy].

Source: Orthopedic Consultant, Bucknell University, SUN Orthopedics and Sports Medicine, Lewisburg. jfuria@sunortho.com

Abstract

PURPOSE: The purpose of this study was to determine the efficacy of extracorporeal shock wave therapy (ESWT) for the treatment of adults with chronic insertional Achilles tendinopathy.

METHODS: 68 patients with chronic insertional Achilles tendinopathy were enrolled in this study. A total of 35 patients were treated with a single dose of ESWT (3000 shocks of 0.20 mJ/mm(2), ESWT group), while 33 patients were treated with traditional non-operative measures (control group).

RESULTS: At 3 months post treatment, the mean VAS for the control and ESWT groups were 2.9 and 7.2 respectively. Using the Roles and Maudsley scale, 39% of the control patients and 51% of the ESWT patients were assigned an excellent or good result.

CONCLUSIONS: ESWT as applied is a safe and effective treatment for chronic insertional Achilles tendinopathy.




A brief biography...
  
Dr. Wayne Coghlan A graduate of the University of Guelph School of Human Biology, and the Canadian Memorial Chiropractic College. I have further education in Sports Sciences, and completed a Master's degree in Counselling Psychology. Played varsity sports - Rugby, Football. Worked my way through school doing physical labour ... I know the realities of the work place. Gardening, canoe trips, Being a good parent.

                         Questions/comments/book and appointment: 
                                                
                                                email me at drwaynecoghlan@gmail.com 
                                                 
                                                 or call me at  705 445-5401

 Links:
http://drwaynecoghlan.blogspot.ca/

Supplementary links:

No comments:

Post a Comment